Substituted [(phenylethanoyl)amino]benzamides

US7776922B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventors

• Ulf Bruggemeier · Leichlingen, DE
• Petros Gatsios · Aachen, DE
• Mark Meininghaus · Wuppertal, DE
• Leila Telan · Wuppertal, DE
• Elisabeth Woltering · Hilden, DE
• Martina Wuttke · Wuppertal, DE
• Hartmut Beck · Wuppertal, DE
• Nils Griebenow · Milford, US
• Frank Süβmeier · Birkenfeld, DE
• Niels Svenstrup · Copenhagen, DK
• Axel Kretschmer · Wuppertal, DE
• Marcus Bauser · Berlin, DE
• Johannes Köbberling · Neuss, DE
• Wahed Ahmed Moradi · Monheim, DE
• Siegfried Zaiss · Wuppertal, DE
• Claudia Hirth-Dietrich · Wuppertal, DE
• Barbara Albrecht · Wuppertal, DE

Key dates

• Filing date: Nov 17, 2005
• Grant date: Aug 17, 2010
• Expiry date: Aug 24, 2026

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to substituted [(phenylethanoyl)amino]benzamides and methods for their preparation, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, in particular of inflammatory disorders such as, for example, cutaneous, respiratory tract and cardiovascular disorders such as, for example, arteriosclerosis and coronary heart disease.